MetLife, Inc.
METNYSEFinancial Services● Active
$84.86
+$0.37(+0.44%)
Market Cap$54.6B
P/E Ratio—
52W High$85.29
52W Low$67.33
MetLife, Inc. (MET) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MET · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$2.42
Est. $2.27 · +6.6%
Revenue
$19.07B
Est. $19.49B · -2.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 3-Quarter EPS Beat Streak
MET reports quarterly as a NYSE-listed Insurance - Life company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $2.39 | — | — | — | $19.77B | — |
| ▲ Q2 FY2026 | May 6, 2026 | $2.27 | $2.42 | +6.6% | $19.07B | $19.49B | -2.1% |
| ▲ Q1 FY2026 | Feb 4, 2026 | $2.34 | $2.58 | +10.3% | $23.81B | $27.22B | -12.5% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $2.31 | $2.34 | +1.3% | $16.88B | $18.64B | -9.4% |
| ▼ Q3 FY2025 | Aug 6, 2025 | $2.15 | $2.02 | -6.0% | $17.34B | $18.53B | -6.5% |
| ▼ Q2 FY2025 | Apr 30, 2025 | $2.00 | $1.96 | -2.0% | $18.28B | $18.37B | -0.5% |
| ▼ Q1 FY2025 | Feb 5, 2025 | $2.11 | $2.08 | -1.4% | $18.38B | $19.50B | -5.8% |
| ▼ Q4 FY2024 | Oct 30, 2024 | $2.17 | $1.95 | -10.1% | $18.44B | $18.66B | -1.2% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$2.39
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Beat
EPS Actual
$2.42
EPS Est.
$2.27
EPS Surpr.
+6.6%
Revenue
$19.07B
Q1 FY2026
Feb 4, 2026Beat
EPS Actual
$2.58
EPS Est.
$2.34
EPS Surpr.
+10.3%
Revenue
$23.81B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$2.34
EPS Est.
$2.31
EPS Surpr.
+1.3%
Revenue
$16.88B
Q3 FY2025
Aug 6, 2025Miss
EPS Actual
$2.02
EPS Est.
$2.15
EPS Surpr.
-6.0%
Revenue
$17.34B
Q2 FY2025
Apr 30, 2025Miss
EPS Actual
$1.96
EPS Est.
$2.00
EPS Surpr.
-2.0%
Revenue
$18.28B
Q1 FY2025
Feb 5, 2025Miss
EPS Actual
$2.08
EPS Est.
$2.11
EPS Surpr.
-1.4%
Revenue
$18.38B
Q4 FY2024
Oct 30, 2024Miss
EPS Actual
$1.95
EPS Est.
$2.17
EPS Surpr.
-10.1%
Revenue
$18.44B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $3.34 | $3.56 | $3.72 | 4 |
| Q3 FY2029 | $3.35 | $3.57 | $3.74 | 4 |
| Q2 FY2029 | $3.30 | $3.52 | $3.68 | 4 |
| Q1 FY2029 | $2.70 | $2.87 | $3.01 | 4 |
| Q4 FY2028 | $3.01 | $3.20 | $3.35 | 5 |
| Q3 FY2028 | $3.01 | $3.21 | $3.36 | 5 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $22.8B | $23.9B | $24.8B | 2 |
| Q3 FY2029 | $21.9B | $23.0B | $23.8B | 2 |
| Q2 FY2029 | $21.8B | $22.8B | $23.7B | 2 |
| Q1 FY2029 | $22.1B | $23.2B | $24.0B | 2 |
| Q4 FY2028 | $21.6B | $22.6B | $23.5B | 1 |
| Q3 FY2028 | $21.1B | $22.2B | $23.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +6.6% | $79.90 | $80.16 | +0.33% |
| ▲ Q1 FY2026 | Feb 4, 2026 | +10.3% | $76.90 | $78.01 | +1.44% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +1.3% | $79.46 | $78.68 | -0.98% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -6.0% | $74.89 | $75.95 | +1.42% |
| ▼ Q2 FY2025 | Apr 30, 2025 | -2.0% | $76.42 | $75.37 | -1.37% |
| ▼ Q1 FY2025 | Feb 5, 2025 | -1.4% | $84.63 | $85.00 | +0.44% |
| ▼ Q4 FY2024 | Oct 30, 2024 | -10.1% | $82.83 | $83.18 | +0.42% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +8.6% | $76.75 | $76.85 | +0.13% |
Q2 FY2026+0.33%
Report Date
May 6, 2026
EPS Beat/Miss
+6.6%
Price Before
$79.90
Price After
$80.16
Q1 FY2026+1.44%
Report Date
Feb 4, 2026
EPS Beat/Miss
+10.3%
Price Before
$76.90
Price After
$78.01
Q4 FY2025-0.98%
Report Date
Nov 5, 2025
EPS Beat/Miss
+1.3%
Price Before
$79.46
Price After
$78.68
Q3 FY2025+1.42%
Report Date
Aug 6, 2025
EPS Beat/Miss
-6.0%
Price Before
$74.89
Price After
$75.95
Q2 FY2025-1.37%
Report Date
Apr 30, 2025
EPS Beat/Miss
-2.0%
Price Before
$76.42
Price After
$75.37
Q1 FY2025+0.44%
Report Date
Feb 5, 2025
EPS Beat/Miss
-1.4%
Price Before
$84.63
Price After
$85.00
Q4 FY2024+0.42%
Report Date
Oct 30, 2024
EPS Beat/Miss
-10.1%
Price Before
$82.83
Price After
$83.18
Q3 FY2024+0.13%
Report Date
Jul 31, 2024
EPS Beat/Miss
+8.6%
Price Before
$76.75
Price After
$76.85
Avg Beat Reaction+0.23%
Avg Miss Reaction+0.23%
Beat Rate4 / 8 quarters
Largest Move+1.44% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MET ends December
MetLife, Inc. (MET) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $2.42 — beating the analyst consensus of $2.27 by +6.6%. MET has beaten EPS estimates for 3 consecutive quarters. The next MET earnings date is expected around September 1, 2026.
Each quarter, investors track MET earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MET revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MET's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MET earnings · 5 questionsMetLife, Inc.'s next earnings report is expected around September 1, 2026. MET typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MET historically reports after market close (AMC).
MET earnings datewhen is MET earningsMET next earnings datewhen does MET report earningsMET earnings calendar
▸ Source: FMP · MetLife, Inc. SEC filings · US GAAP · MetLife, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026